Trial Profile
A Double Blind Clinical Trial of DCS for Food Anxiety for Patients With Anorexia and Bulimia Nervosa
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Mar 2018
Price :
$35
*
At a glance
- Drugs Cycloserine (Primary)
- Indications Anorexia; Bulimia nervosa
- Focus Pharmacodynamics
- 09 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 05 Dec 2013 New trial record